Furthermore, we found that there was no statistically significant synergism of selenium and Tz, but that selenium had an additive inhibitory effect and did not antagonize the effect of Tz in HER2-positive breast cancer cells, regardless of the response to Tz. The gene discussed is ERBB2; the disease is breast carcinoma.